Literature DB >> 2143752

Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides.

P J Baker1, C E Taylor, P W Stashak, M B Fauntleroy, K Hasløv, N Qureshi, K Takayama.   

Abstract

Antibody responses of mice immunized with type III pneumococcal polysaccharide were examined with and without treatment with nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides (Rs-LPS). The results obtained were similar to those described previously for mice treated with monophosphoryl lipid A (MPL) except that lower amounts of Rs-LPS were needed. Both were without effect when given at the time of immunization with type III pneumococcal polysaccharide but elicited significant enhancement when given 2 to 3 days later. Such enhancement was T cell dependent and not due to polyclonal activation of immunoglobulin M synthesis by B cells. Treatment with either Rs-LPS or MPL abolished the expression but not induction of low-dose paralysis, a form of immunological unresponsiveness known to be mediated by suppressor T cells (Ts). The in vitro treatment of cell suspensions containing Ts with extremely small amounts of Rs-LPS or MPI completely eliminated the capacity of such cells to transfer suppression to other mice. These findings indicate that the immunomodulatory effects of both MPL and Rs-LPS are mainly the result of eliminating the inhibitors effects of Ts; this permits the positive effects of amplifier T cells to be more fully expressed, thereby resulting in an increased antibody response. The significance of these and other findings to the use of Rs-LPS as a pharmacotherapeutic agent for gram-negative bacterial sepsis is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143752      PMCID: PMC313579          DOI: 10.1128/iai.58.9.2862-2868.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells.

Authors:  J M Jones; D F Amsbaugh; P W Stashak; B Prescott; P J Baker; D W Alling
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

2.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

3.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

4.  Quantitative and qualitative studies on the primary antibody response to pneumococcal polysaccharides at ehe cellular level.

Authors:  P H Baker; P W Stashak
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

5.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.

Authors:  P J Baker; B Prescott; P W Stashak; D F Amsbaugh
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

6.  Application of transformations to normalize the distribution of plaque-forming cells.

Authors:  C F Gottlieb
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

7.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

8.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

Authors:  P J Baker; P W Stashak; B Prescott
Journal:  Appl Microbiol       Date:  1969-03

9.  Position of ester groups in the lipid A backbone of lipopolysaccharides obtained from Salmonella typhimurium.

Authors:  N Qureshi; K Takayama; D Heller; C Fenselau
Journal:  J Biol Chem       Date:  1983-11-10       Impact factor: 5.157

10.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells.

Authors:  P J Baker; N D Reed; P W Stashak; D F Amsbaugh; B Prescott
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.

Authors:  P J Baker
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Differential sensitivity of CD8+ suppressor and cytotoxic T lymphocyte activity to bacterial monophosphoryl lipid A.

Authors:  F Esquivel; C E Taylor; P J Baker
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

3.  TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.

Authors:  Zhongyang Lu; Xiaoming Zhang; Yanchun Li; Maria F Lopes-Virella; Yan Huang
Journal:  Immunobiology       Date:  2015-06-30       Impact factor: 3.144

4.  Alterations in frequency of interleukin-2 (IL-2)-, gamma interferon-, or IL-4-secreting splenocytes induced by Candida albicans mannan and/or monophosphoryl lipid A.

Authors:  S P Li; S I Lee; J E Domer
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

5.  Lipid A-mediated tolerance and cancer therapy.

Authors:  Cheryl E Rockwell; David C Morrison; Nilofer Qureshi
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  Splenic T-lymphocyte functions during early syphilitic infection are complex.

Authors:  T J Fitzgerald; M A Tomai
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity.

Authors:  P J Baker; T Hraba; C E Taylor; K R Myers; K Takayama; N Qureshi; P Stuetz; S Kusumoto; A Hasegawa
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

8.  Characterization of lipopolysaccharides present in settled house dust.

Authors:  Ju-Hyeong Park; Bogumila Szponar; Lennart Larsson; Diane R Gold; Donald K Milton
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

9.  Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice.

Authors:  F S Ekwunife; C E Taylor; M B Fauntleroy; P W Stashak; P J Baker
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

10.  Pellino-1 Regulates Immune Responses to Haemophilus influenzae in Models of Inflammatory Lung Disease.

Authors:  Bethany M Hughes; Charlotte S Burton; Abigail Reese; Maisha F Jabeen; Carl Wright; Jessica Willis; Nika Khoshaein; Elizabeth K Marsh; Peter Peachell; Shao C Sun; David H Dockrell; Helen M Marriott; Ian Sabroe; Alison M Condliffe; Lynne R Prince
Journal:  Front Immunol       Date:  2019-07-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.